Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,059,003 papers from all fields of science
Search
Sign In
Create Free Account
Muzolimine
Known as:
3H-Pyrazol-3-one, 5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-2,4-dihydro-
, Muzolimine [Chemical/Ingredient]
A pyrazole diuretic with long duration and high capacity of action. It was proposed for kidney failure and hypertension but was withdrawn worldwide…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Broader (2)
Antihypertensive Agents
Diuretics
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Inhibition of the Cl-/NaCO3- anion exchanger by xipamide in human red blood cells.
C. Nazaret
,
J. Díez
,
P. Hannaert
,
M. Christen
,
N. Wierzbicki
,
R. Garay
European Journal of Pharmacology
1987
Corpus ID: 4535032
1987
1987
The diuretic effect of muzolimine
P. Wangemann
,
R. Braitsch
,
R. Greger
Pflügers Archiv
1987
Corpus ID: 19367481
Muzolimine produces a diuresis in the loop of Henle. Unlike other diuretics of this kind, the effect of muzolimine is slow and…
Expand
1986
1986
Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: Comparison with furosemide
M. Bernardi
,
R. De Palma
,
+5 authors
Govanni Gasbarrini
Hepatology
1986
Corpus ID: 205862916
Muzolimine is a loop diuretic with both the dosedepend increasing effectiveness of loop diurexctics and the long‐lasting effect…
Expand
1985
1985
The metabolism of muzolimine.
J. Gorrod
,
P. Messis
,
W. Ritter
Zeitschrift für Kardiologie
1985
Corpus ID: 351228
The metabolism of muzolimine, 3-amino-1-(3,4-dichloro-alpha-methyl-benzyl)-2-pyrazoline-5-one has been studied both in vivo and…
Expand
1985
1985
Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
R. Kirsten
,
K. Molz
,
I. Tzonév
,
K. Nelson
Zeitschrift für Kardiologie
1985
Corpus ID: 28667940
Muzolimine, a new saliuretic, has been shown to combine high ceiling and long-acting effects in animal experiments. This study…
Expand
1985
1985
Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
M. Bernardi
,
R. Depalma
,
F. Trevisani
,
C. Santini
,
D. Servadei
,
G. Gasbarrini
Zeitschrift für Kardiologie
1985
Corpus ID: 20717832
Ten male cirrhotic patients with ascites and reduced renal function were randomly given equivalent doses of furosemide and…
Expand
1985
1985
Demonstration of action of muzolimine on the serosal side of Henle's loop cells.
R. Faedda
,
A. Satta
,
G. Branca
,
B. Contu
,
E. Bartoli
Zeitschrift für Kardiologie
1985
Corpus ID: 12123648
Muzolimine, a new diuretic, is known to act by inhibiting Na transport along the ascending limb of Henle's loop. Because of its…
Expand
1985
1985
Muzolimine and nitrendipine in the treatment of arterial hypertension.
O. de Divitiis
,
S. Di Somma
,
M. Petitto
,
M. Galderisi
,
C. Iacono
,
S. Fazio
Zeitschrift für Kardiologie
1985
Corpus ID: 7273780
Thirty patients with moderate to severe hypertension (diastolic blood pressure greater than or equal to 115 mmHg), after a run-in…
Expand
1985
1985
Muzolimine in patients on chronic hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD).
G. Bandiani
,
E. Camaiora
,
M. A. Nicolini
,
U. Perotta
Zeitschrift für Kardiologie
1985
Corpus ID: 25234346
The importance of the urine volume and the residual functional capacity of the kidneys has been emphasized by several authors in…
Expand
1982
1982
Adequate substitution with electrolytes in toxicological testing of "loop" diuretics in the dog.
B. Garthoff
,
K. Hoffmann
,
G. Luckhaus
,
K. Thurau
Toxicology and Applied Pharmacology
1982
Corpus ID: 7385665
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required